HAE Haemonetics Corporation Common Stock
$102,60
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$47–$106
94% of range
Ocena Analityków
BUY
15 analysts
Cena Docelowa
$96
P/E (TTM)
50.0
ROE
11.8%
Marża Zysku Netto
7.3%
O Haemonetics Corporation Common Stock Przegląd firmy z Wikipedii
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Czytaj więcej
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
History
The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.
In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.
Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.
In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.
Product categories
Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.
Hemostasis
TEG 5000
Kaolin TEG
Kaolin TEG with Heparinase
RapidTEG
TEG Functional Fibrinogen
TEG PlateletMapping
TEG 6S
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
HAE Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$102.59
Kapitalizacja Rynkowa
$4.64B
P/E (TTM)
50.0
EPS (TTM)
$2.05
Przychody (TTM)
$1.33B
Stopa dywidendy
—
ROE
11.8%
D/E Dług/Kapitał
1.5
Zakres 52 tyg.
$47 – $106
HAE Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$1.33B
2017-04-01
→
2026-03-28
EPS
$2.05
2017-04-01
→
2026-03-28
Wolny przepływ pieniężny
$260M
2017-04-01
→
2026-03-28
Marże
7.3%
2017-04-01
→
2026-03-28
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
HAE
Mediana porównawcza
P/E (TTM)
50.0
39.4
P/S (TTM)
3.5
2.1
P/B
5.8
3.3
EV / EBITDA
35.9
—
Price / FCF (Cena / FCF)
17.8
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
HAE
Mediana porównawcza
Gross Margin (Marża brutto)
59.0%
58.7%
Operating Margin (Marża Operacyjna)
11.8%
—
Net Profit Margin (Marża Zysku Netto)
7.3%
-11.8%
ROA
4.0%
-6.3%
ROE
11.8%
-13.4%
ROIC
5.9%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
HAE
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
1.5
37.4
Current Ratio (Wskaźnik bieżący)
3.0
2.4
Quick Ratio (Wskaźnik Szybkości)
1.6
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
HAE
Mediana porównawcza
Revenue YoY (Przychody R/R)
-2.0%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
4.5%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
8.9%
—
EPS YoY
-38.1%
—
Net Income YoY (Zysk Netto R/R)
-42.0%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
HAE
Mediana porównawcza
HAE Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
15 analityków
- Mocne kupno 5 33,3%
- Kup 6 40,0%
- Trzymaj 4 26,7%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
10 analityków · 2026-08-13
Mediana
$95.50
Teraz
$102.59
Niski
$86.00
Wysoki
$105.00
Średni cel
$95.50
-6,9%
Średnia cel
$96.20
-6,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.06%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2027 | $1.14 | $1.09 | 0.05% |
| 30 czerwca 2026 | $1.14 | $1.09 | 0.05% |
| 31 marca 2026 | $1.29 | $1.28 | 0.01% |
| 31 grudnia 2025 | $1.31 | $1.26 | 0.05% |
| 30 września 2025 | $1.27 | $1.12 | 0.15% |
| 30 czerwca 2025 | $1.10 | $1.03 | 0.07% |
| 31 marca 2025 | $1.24 | $1.23 | 0.01% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
Bilans 25
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
Rentowność 8
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
Efektywność 3
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
Stopy Wzrostu 9
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
Bilans 25
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
Przepływy pieniężne 13
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
Efektywność 3
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Przychody | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| Marża Brutto % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Marża Operacyjna % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| Zysk netto | $97M | $168M | $118M | $115M | $43M |
| Rozwodniony EPS | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
Bilans
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| Wskaźnik bieżący | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| Wskaźnik Szybkości | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
Przepływy pieniężne
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $260M | $142M | $115M | $163M | $76M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 361 emitentów · $2.6B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 61 (+8 vs poprzedni kw.) | 42 (-14 vs poprzedni kw.) | 108 (-4 vs poprzedni kw.) | 112 (-2 vs poprzedni kw.) | +6.3M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349 945 961 | 4 366 138 | 13,44% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $308 172 249 | 4 108 761 | 11,84% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190 979 550 | 2 546 394 | 7,34% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $154 468 350 | 2 059 578 | 5,93% | Akcje |
| STATE STREET CORP | $136 363 950 | 1 818 186 | 5,24% | Akcje |
| CITADEL ADVISORS LLC | $113 259 000 | 1 510 120 | 4,35% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $109 143 975 | 1 455 253 | 4,19% | Akcje |
| River Road Asset Management, LLC | $96 420 150 | 1 285 602 | 3,70% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86 651 325 | 1 155 351 | 3,33% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $79 315 930 | 1 057 321 | 3,05% | Akcje |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62 319 375 | 830 925 | 2,39% | Akcje |
| GOLDMAN SACHS GROUP INC | $52 644 150 | 701 922 | 2,02% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44 356 725 | 591 423 | 1,70% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $42 780 975 | 570 413 | 1,64% | Akcje |
| Holocene Advisors, LP | $41 264 625 | 550 195 | 1,59% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37 034 909 | 493 796 | 1,42% | Akcje |
| North Peak Capital Management, LLC | $25 730 775 | 343 077 | 0,99% | Akcje |
| LONDON CO OF VIRGINIA | $25 543 299 | 340 574 | 0,98% | Akcje |
| DEUTSCHE BANK AG\ | $25 282 575 | 337 101 | 0,97% | Akcje |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24 905 625 | 332 075 | 0,96% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $24 779 850 | 330 398 | 0,95% | Akcje |
| Boston Trust Walden Corp | $24 170 475 | 322 273 | 0,93% | Akcje |
| Aristotle Capital Boston, LLC | $21 721 809 | 289 624 | 0,83% | Akcje |
| MIZUHO MARKETS AMERICAS LLC | $21 166 050 | 282 214 | 0,81% | Akcje |
| BANK OF AMERICA CORP /DE/ | $20 122 875 | 268 305 | 0,77% | Akcje |
| Invenomic Capital Management LP | $16 216 275 | 216 217 | 0,62% | Akcje |
| FMR LLC | $15 638 325 | 208 511 | 0,60% | Akcje |
| HEARTLAND ADVISORS INC | $15 000 000 | 200 000 | 0,58% | Akcje |
| GLENMEDE TRUST CO NA | $14 454 000 | 192 720 | 0,56% | Akcje |
| MORGAN STANLEY | $13 073 475 | 174 313 | 0,50% | Akcje |
| Longaeva Partners L.P. | $12 286 650 | 163 822 | 0,47% | Akcje |
| RHUMBLINE ADVISERS | $10 812 225 | 144 163 | 0,42% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $10 613 250 | 141 510 | 0,41% | Akcje |
| Balyasny Asset Management L.P. | $10 123 575 | 134 981 | 0,39% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $9 750 000 | 130 000 | 0,37% | Akcje |
| Point72 Asset Management, L.P. | $8 192 700 | 109 236 | 0,31% | Akcje |
| Verition Fund Management LLC | $7 913 100 | 105 508 | 0,30% | Akcje |
| ARIEL INVESTMENTS, LLC | $7 569 975 | 100 933 | 0,29% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $7 500 000 | 100 000 | 0,29% | Opcja kupna |
| KESTREL INVESTMENT MANAGEMENT CORP | $7 305 000 | 97 400 | 0,28% | Akcje |
| Divisadero Street Capital Management, LP | $7 234 425 | 96 459 | 0,28% | Akcje |
| Swiss National Bank | $6 997 500 | 93 300 | 0,27% | Akcje |
| GOLDMAN SACHS GROUP INC | $6 750 000 | 90 000 | 0,26% | Opcja kupna |
| GOLDMAN SACHS GROUP INC | $6 750 000 | 90 000 | 0,26% | Opcja sprzedaży |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 510 000 | 86 800 | 0,25% | Opcja kupna |
| Squarepoint Ops LLC | $6 459 300 | 86 124 | 0,25% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $6 215 025 | 82 867 | 0,24% | Akcje |
| Quantinno Capital Management LP | $5 477 550 | 73 034 | 0,21% | Akcje |
| ROYCE & ASSOCIATES LP | $5 360 625 | 71 475 | 0,21% | Akcje |
| AMERIPRISE FINANCIAL INC | $5 358 525 | 71 447 | 0,21% | Akcje |
| JUPITER ASSET MANAGEMENT LTD | $5 229 300 | 69 724 | 0,20% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $5 166 634 | 91 672 | 0,20% | Akcje |
| SEGALL BRYANT & HAMILL, LLC | $5 106 900 | 68 092 | 0,20% | Akcje |
| AMERICAN CAPITAL MANAGEMENT INC | $5 018 625 | 66 915 | 0,19% | Akcje |
| ISTHMUS PARTNERS, LLC | $4 946 325 | 65 951 | 0,19% | Akcje |
| Corient Private Wealth LP | $4 851 975 | 64 693 | 0,19% | Akcje |
| FIRST TRUST ADVISORS LP | $4 751 850 | 63 358 | 0,18% | Akcje |
| DEAN INVESTMENT ASSOCIATES, LLC | $4 649 175 | 61 989 | 0,18% | Akcje |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4 497 450 | 59 966 | 0,17% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4 484 325 | 59 791 | 0,17% | Akcje |
| Bridgewater Associates, LP | $4 479 975 | 59 733 | 0,17% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $4 181 475 | 55 753 | 0,16% | Akcje |
| Trexquant Investment LP | $3 946 425 | 52 619 | 0,15% | Akcje |
| Aequim Alternative Investments LP | $3 840 000 | 51 200 | 0,15% | Akcje |
| RICE HALL JAMES & ASSOCIATES, LLC | $3 827 850 | 51 038 | 0,15% | Akcje |
| JANE STREET GROUP, LLC | $3 682 500 | 49 100 | 0,14% | Opcja kupna |
| MetLife Investment Management, LLC | $3 681 075 | 49 081 | 0,14% | Akcje |
| BlackRock, Inc. | $3 618 975 | 48 253 | 0,14% | Akcje |
| Retirement Systems of Alabama | $3 604 875 | 48 065 | 0,14% | Akcje |
| Riverwater Partners LLC | $3 573 375 | 47 645 | 0,14% | Akcje |
| Skylands Capital, LLC | $3 571 875 | 47 625 | 0,14% | Akcje |
| FIFTH THIRD BANCORP | $3 561 472 | 47 486 | 0,14% | Akcje |
| ALGERT GLOBAL LLC | $3 522 750 | 46 970 | 0,14% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $3 441 750 | 45 890 | 0,13% | Akcje |
| Qube Research & Technologies Ltd | $3 425 475 | 45 673 | 0,13% | Akcje |
| Dean Capital Management | $3 372 600 | 44 968 | 0,13% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $3 351 375 | 44 685 | 0,13% | Akcje |
| EASTERLY INVESTMENT PARTNERS LLC | $3 248 025 | 43 307 | 0,12% | Akcje |
| Phocas Financial Corp. | $3 227 250 | 43 030 | 0,12% | Akcje |
| ZB,N.A. | $3 200 968 | 40 996 | 0,12% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3 190 200 | 42 536 | 0,12% | Akcje |
| CONNORS INVESTOR SERVICES INC | $3 150 000 | 42 000 | 0,12% | Akcje |
| Expect Equity LLC | $3 076 950 | 41 026 | 0,12% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 964 874 | 52 606 | 0,11% | Akcje |
| BEACON INVESTMENT ADVISORS LLC | $2 783 648 | 37 115 | 0,11% | Akcje |
| Campbell & CO Investment Adviser LLC | $2 763 300 | 36 844 | 0,11% | Akcje |
| Assenagon Asset Management S.A. | $2 633 175 | 35 109 | 0,10% | Akcje |
| BARCLAYS PLC | $2 448 300 | 32 644 | 0,09% | Akcje |
| MARSHALL WACE, LLP | $2 286 975 | 30 493 | 0,09% | Akcje |
| Cubist Systematic Strategies, LLC | $2 219 702 | 45 541 | 0,09% | Akcje |
| XTX Topco Ltd | $2 208 150 | 29 442 | 0,08% | Akcje |
| Legal & General Group Plc | $2 032 875 | 27 105 | 0,08% | Akcje |
| CARY STREET PARTNERS FINANCIAL LLC | $1 999 800 | 26 664 | 0,08% | Akcje |
| Nierenberg Investment Management Company, LLC | $1 971 000 | 26 280 | 0,08% | Akcje |
| Aurora Investment Counsel | $1 912 575 | 25 501 | 0,07% | Akcje |
| WESBANCO BANK INC | $1 912 500 | 25 500 | 0,07% | Akcje |
| Cardinal Capital Management | $1 861 275 | 24 817 | 0,07% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $1 846 275 | 24 617 | 0,07% | Akcje |
| Legato Capital Management LLC | $1 758 750 | 23 450 | 0,07% | Akcje |
| CITADEL ADVISORS LLC | $1 740 000 | 23 200 | 0,07% | Opcja kupna |
Insiderzy spółki 72 insiderów · 48 dyrektorzy generalni · 25 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 15 maja 2026 A | 444 704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 15 września 2015 M | 147 040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 15 maja 2026 A | 54 444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 23 sierpnia 2021 M | 30 291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 13 stycznia 2016 A | 56 743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 1 listopada 2006 P | 2 101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 26 lipca 2024 S | 18 196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 25 października 2016 A | 23 318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 6 lipca 2015 M | 34 102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 11 listopada 2013 M | 10 987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 3 maja 2012 M | 4 442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 8 sierpnia 2008 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 1 maja 2008 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 28 listopada 2007 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 14 czerwca 2007 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 1 listopada 2006 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 2 maja 2005 P | 2 347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 15 maja 2026 A | 32 936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 23 października 2015 S | 16 891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 5 czerwca 2026 F | 6 242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 5 czerwca 2026 F | 40 987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 15 maja 2026 A | 39 882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 15 maja 2026 A | 68 829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 12 lipca 2024 S | 21 331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 28 maja 2024 F | 30 940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 13 czerwca 2022 S | 4 447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 7 czerwca 2021 S | 4 216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 11 listopada 2019 S | 1 977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 7 czerwca 2018 S | 15 226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 25 października 2016 A | 16 867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 25 października 2016 A | 48 166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 26 października 2015 S | 30 507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 26 października 2015 S | 20 464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 23 października 2015 S | 16 235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 13 kwietnia 2015 D | 13 216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 28 sierpnia 2014 S | 5 013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 24 lipca 2013 A | 7 618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 30 kwietnia 2013 P | 17 279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 4 maja 2011 P | 3 052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 5 kwietnia 2011 D | 2 815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 4 listopada 2010 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 29 lipca 2010 A | 10 580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 1 maja 2009 P | 15 849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 1 maja 2008 P | 1 041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 1 maja 2008 P | 12 188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 1 maja 2008 P | 4 891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 1 maja 2008 P | 3 024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 4 maja 2007 M | 4 193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | Dyrektor | 24 lipca 2026 A | 15 471 | 0 | 0 | $0 |
| Diane M Bryant | Dyrektor | 24 lipca 2026 A | 9 664 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 8 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 6 lutego 2004 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 20 sierpnia 2003 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 8 sierpnia 2003 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 24 czerwca 2003 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 19 czerwca 2003 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 3 czerwca 2003 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 27 maja 2003 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 15 czerwca 2001 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 87 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1,86% | 61 981 NS | 31 maja 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,84% | 43 927 NS | 30 kwietnia 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,77% | 125 093 NS | 30 kwietnia 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,64% | 5 836 NS | 30 kwietnia 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,46% | 12 701 NS | 31 maja 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,35% | 201 070 NS | 30 kwietnia 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,32% | 35 814 NS | 31 maja 2026 | N-PORT |
| ABCS · EA Series Trust | 0,31% | 522 NS | 29 maja 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,24% | 41 437 NS | 30 kwietnia 2026 | N-PORT |
| IWO · iShares Trust | 0,23% | 402 938 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 75 831 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,20% | 47 624 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,19% | 76 694 NS | 31 maja 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 17 393 NS | 30 kwietnia 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0,13% | 63 NS | 29 maja 2026 | N-PORT |
| IJK · iShares Trust | 0,13% | 163 140 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,13% | 1 201 903 SH | 8 sierpnia 2026 | Dziennie |
| BKSE · BNY Mellon ETF Trust | 0,13% | 1 703 NS | 30 kwietnia 2026 | N-PORT |
| XJH · iShares Trust | 0,12% | 6 299 SH | 8 sierpnia 2026 | Dziennie |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 12 097 NS | 30 kwietnia 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 24 558 SH | 8 sierpnia 2026 | Dziennie |
| SMDX · Tidal Trust III | 0,12% | 2 419 NS | 30 kwietnia 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,11% | 27 512 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 271 486 SH | 8 sierpnia 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,11% | 23 551 NS | 30 kwietnia 2026 | N-PORT |
| IJH · iShares Trust | 0,11% | 1 603 400 SH | 8 sierpnia 2026 | Dziennie |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 42 163 NS | 30 kwietnia 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,11% | 5 312 SH | 8 sierpnia 2026 | Dziennie |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,10% | 74 976 SH | 8 sierpnia 2026 | Dziennie |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 126 817 NS | 31 maja 2026 | N-PORT |
| IJJ · iShares Trust | 0,09% | 94 775 SH | 8 sierpnia 2026 | Dziennie |
| EBIT · Harbor ETF Trust | 0,09% | 168 NS | 30 kwietnia 2026 | N-PORT |
| ESML · iShares Trust | 0,09% | 29 374 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,09% | 20 324 NS | 30 kwietnia 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,08% | 15 968 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,08% | 2 210 NS | 31 maja 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,08% | 5 212 NS | 30 kwietnia 2026 | N-PORT |
| ISCV · iShares Trust | 0,07% | 6 131 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,07% | 159 737 NS | 30 kwietnia 2026 | N-PORT |
| MVV · ProShares Trust | 0,07% | 1 606 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 222 776 NS | 31 maja 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 12 283 NS | 30 kwietnia 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,06% | 9 034 SH | 8 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,06% | 1 979 SH | 8 sierpnia 2026 | Dziennie |
| SMLF · iShares Trust | 0,06% | 28 701 SH | 8 sierpnia 2026 | Dziennie |
| MIDU · Direxion Shares ETF Trust | 0,06% | 770 NS | 30 kwietnia 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,05% | 2 220 NS | 31 maja 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 1 979 NS | 31 maja 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 302 003 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,05% | 139 826 SH | 8 sierpnia 2026 | Dziennie |